Cosmos HealthCOSM +17.09%29 5-Year Yield-on-Cost % is 0.00 as of Jul. 02, 2026. GuruFocus rates COSM with a GF Score™ of 29/100 and a GF Value™ of $0.36 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 69 Medical Distribution companies, Cosmos Health ranks worse than 1449273.91% on this metric.
Cosmos Health's yield on cost for the quarter that ended in Mar. 2026 was 0.00.
The historical rank and industry rank for Cosmos Health's 5-Year Yield-on-Cost % or its related term are showing as below:
COSM's 5-Year Yield-on-Cost % is not ranked *
in the Medical Distribution industry.
Industry Median: 3.33 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Cosmos Health (NAS:COSM) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Cosmos Health 5-Year Yield-on-Cost % Related Terms
COSM vs HKPD, SNYR, YI: 5-Year Yield-on-Cost % Comparison
For the Medical Distribution subindustry, Cosmos Health's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cosmos Health 5-Year Yield-on-Cost % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Cosmos Health's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Cosmos Health's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Cosmos Health is calculated as
Cosmos Health (COSM) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 02, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Cosmos Health and its competitors. According to the industry distribution chart, Cosmos Health ranks #999999 out of 69 companies in the Medical Distribution industry.
Is Cosmos Health's 5-Year Yield-on-Cost % too high?
Cosmos Health's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Cosmos Health ranks #999999 out of 69 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Cosmos Health has a GF Score™ of 29/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cosmos Health's 5-Year Yield-on-Cost % compare to HKPD and SNYR?
According to the Medical Distribution industry distribution chart, Cosmos Health ranks #999999 out of 69 companies for 5-Year Yield-on-Cost %. This places Cosmos Health in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 3.33. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Distribution company?
The median 5-Year Yield-on-Cost % among Medical Distribution companies is 3.33, based on 69 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Cosmos Health and its competitors. For the Medical Distribution industry, the median 5-Year Yield-on-Cost % is 3.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cosmos Health's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cosmos Health stock overvalued right now?
Based on GuruFocus' analysis, Cosmos Health (COSM) is currently considered Possible Value Trap. The stock's GF Value™ is $0.36, compared to a current price of $0.24 — trading 34.1% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Cosmos Health's overall GF Score™ is 29/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Cosmos Health (COSM), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cosmos Health (COSM) Overvalued in 2026?
Based on GuruFocus' analysis, Cosmos Health stock appears to be undervalued.
The current stock price of $0.24 is trading 34.1% below its estimated GF Value™ of $0.36.
GuruFocus considers Cosmos Health to be Possible Value Trap.
Key valuation signals for COSM:
5-Year Yield-on-Cost %: 0.00
GF Value™: $0.36 vs. price of $0.24 (34.1% below fair value)
No single metric tells the full story. See the COSM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
29GF Score
Get the complete analysis for COSM
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
COSM has been successfully added to your 